Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      COMPLICATIONS of cardiac surgery; INFECTION; DRUG dosage; SURGICAL site infection prevention; CEPHALOSPORINS; COMPARATIVE studies; DRUG administration; CARDIAC surgery; RESEARCH methodology; INTRAOPERATIVE care; MEDICAL cooperation; RESEARCH; TIME; EVALUATION research; CEFAZOLIN; RETROSPECTIVE studies; ANTIBIOTIC prophylaxis; THERAPEUTICS
    • Abstract:
      Intraoperative redosing of prophylactic antibiotics is recommended for prolonged surgical procedures, although its efficacy has not been assessed. We retrospectively compared the risk of surgical site infections in 1,548 patients who underwent cardiac surgery lasting >240 min after preoperative administration of cefazolin prophylaxis. The overall risk of surgical site infection was similar among patients with (43 [9.4%] of 459) and without (101 [9.3%] of 1,089) intraoperative redosing (odds ratio [OR] 1.01, 95% confidence interval [CI] 0.70-1.47). However, redosing was beneficial in procedures lasting >400 min: infection occurred in 14 (7.7%) of 182 patients with redosing and in 32 (16.0%) of 200 patients without (adjusted OR 0.44, 95% CI 0.23-0.86). Intraoperative redosing of cefazolin was associated with a 16% reduction in the overall risk for surgical site infection after cardiac surgery, including procedures lasting <240 min. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Emerging Infectious Diseases is the property of Centers for Disease Control & Prevention (CDC) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)